{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,21]],"date-time":"2026-10-21T03:29:33Z","timestamp":1792553373398,"version":"4.5.0"},"reference-count":21,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2022,9,1]],"date-time":"2022-09-01T00:00:00Z","timestamp":1661990400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,9,1]],"date-time":"2022-09-01T00:00:00Z","timestamp":1661990400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,8,30]],"date-time":"2022-08-30T00:00:00Z","timestamp":1661817600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","epilepsybehavior.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Epilepsy & Behavior"],"published-print":{"date-parts":[[2022,9]]},"DOI":"10.1016\/j.yebeh.2022.108811","type":"journal-article","created":{"date-parts":[[2022,7,8]],"date-time":"2022-07-08T12:49:43Z","timestamp":1657284583000},"page":"108811","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":19,"special_numbering":"C","title":["Quality-of-life results in adults with epilepsy using diazepam nasal spray for seizure clusters from a long-term, open-label safety study"],"prefix":"10.1016","volume":"134","author":[{"given":"Joyce A.","family":"Cramer","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Edward","family":"Faught","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Charles","family":"Davis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sunita N.","family":"Misra","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Enrique","family":"Carrazana","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Adrian L.","family":"Rabinowicz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.yebeh.2022.108811_b0005","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1097\/NRL.0000000000000140","article-title":"Burden of seizure clusters on patients with epilepsy and caregivers: survey of patient, caregiver, and clinician perspectives","volume":"22","author":"Penovich","year":"2017","journal-title":"Neurologist"},{"key":"10.1016\/j.yebeh.2022.108811_b0010","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1016\/j.yebeh.2015.04.022","article-title":"Use of an online epilepsy diary to characterize repetitive seizures","volume":"47","author":"Fisher","year":"2015","journal-title":"Epilepsy Behav"},{"key":"10.1016\/j.yebeh.2022.108811_b0015","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1097\/WCO.0000000000000177","article-title":"Seizure clusters: characteristics and treatment","volume":"28","author":"Haut","year":"2015","journal-title":"Curr Opin Neurol"},{"key":"10.1016\/j.yebeh.2022.108811_b0020","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1016\/j.seizure.2018.05.013","article-title":"Seizure cluster: definition, prevalence, consequences, and management","volume":"68","author":"Jafarpour","year":"2019","journal-title":"Seizure"},{"key":"10.1016\/j.yebeh.2022.108811_b0025","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1212\/CPJ.0000000000000099","article-title":"Development of benzodiazepines for out-of-hospital management of seizure emergencies","volume":"5","author":"Agarwal","year":"2015","journal-title":"Neurol Clin Pract"},{"key":"10.1016\/j.yebeh.2022.108811_b0030","unstructured":"Neurelis, Inc. Valtoco (diazepam nasal spray). Full Prescribing Information. San Diego, CA: Neurelis, Inc.; 2021."},{"key":"10.1016\/j.yebeh.2022.108811_b0035","unstructured":"US Food and Drug Administration. Clinical Superiority Findings, https:\/\/www.fda.gov\/industry\/designating-orphan-product-drugs-and-biological-products\/clinical-superiority-findings; 2019 [accessed June 23, 2020]."},{"key":"10.1016\/j.yebeh.2022.108811_b0040","doi-asserted-by":"crossref","first-page":"108013","DOI":"10.1016\/j.yebeh.2021.108013","article-title":"Examining the patient and caregiver experience with diazepam nasal spray for seizure clusters: results from an exit survey of a phase 3, open-label, repeat-dose safety study","volume":"121","author":"Penovich","year":"2021","journal-title":"Epilepsy Behav"},{"issue":"10","key":"10.1016\/j.yebeh.2022.108811_b0045","doi-asserted-by":"crossref","first-page":"2485","DOI":"10.1111\/epi.17041","article-title":"Final results from a phase 3, long-term, open-label, repeat-dose safety study of diazepam nasal spray for seizure clusters in patients with epilepsy","volume":"62","author":"Wheless","year":"2021","journal-title":"Epilepsia"},{"key":"10.1016\/j.yebeh.2022.108811_b0050","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1111\/j.1528-1157.1998.tb01278.x","article-title":"Development and cross-cultural translations of a 31-item quality of life in epilepsy inventory","volume":"39","author":"Cramer","year":"1998","journal-title":"Epilepsia"},{"key":"10.1016\/j.yebeh.2022.108811_b0055","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1016\/S1525-5050(03)00004-0","article-title":"Maintenance of improvement in health-related quality of life during long-term treatment with levetiracetam","volume":"4","author":"Cramer","year":"2003","journal-title":"Epilepsy Behav"},{"key":"10.1016\/j.yebeh.2022.108811_b0060","doi-asserted-by":"crossref","first-page":"230","DOI":"10.1016\/j.yebeh.2011.12.023","article-title":"Defining minimally important change in QOLIE-31 scores: estimates from three placebo-controlled lacosamide trials in patients with partial-onset seizures","volume":"23","author":"Borghs","year":"2012","journal-title":"Epilepsy Behav"},{"key":"10.1016\/j.yebeh.2022.108811_b0065","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1016\/j.yebeh.2016.11.031","article-title":"Health-related quality of life in double-blind phase III studies of brivaracetam as adjunctive therapy of focal seizures: a pooled, post-hoc analysis","volume":"69","author":"Brandt","year":"2017","journal-title":"Epilepsy Behav"},{"key":"10.1016\/j.yebeh.2022.108811_b0070","doi-asserted-by":"crossref","first-page":"108550","DOI":"10.1016\/j.yebeh.2021.108550","article-title":"Comment on \u201cIntranasal midazolam versus intravenous\/rectal benzodiazepines for acute seizure control in children: A systematic review and meta-analysis\u201d","volume":"128","author":"Wheless","year":"2022","journal-title":"Epilepsy Behav"},{"key":"10.1016\/j.yebeh.2022.108811_b0075","doi-asserted-by":"crossref","first-page":"107312","DOI":"10.1016\/j.yebeh.2020.107312","volume":"112","author":"Cramer","year":"2020","journal-title":"Epilepsy Behav"},{"key":"10.1016\/j.yebeh.2022.108811_b0080","first-page":"CD012081","article-title":"Psychological treatments for people with epilepsy","volume":"10","author":"Michaelis","year":"2017","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1016\/j.yebeh.2022.108811_b0085","doi-asserted-by":"crossref","first-page":"846","DOI":"10.1111\/epi.16847","article-title":"Overcoming the challenges of developing an intranasal diazepam rescue therapy for the treatment of seizure clusters","volume":"62","author":"Cloyd","year":"2021","journal-title":"Epilepsia"},{"issue":"2","key":"10.1016\/j.yebeh.2022.108811_b0090","doi-asserted-by":"crossref","first-page":"208","DOI":"10.1016\/j.yebeh.2007.05.002","article-title":"The effect of seizure severity on quality of life in epilepsy","volume":"11","author":"Harden","year":"2007","journal-title":"Epilepsy Behav"},{"key":"10.1016\/j.yebeh.2022.108811_b0095","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1016\/j.seizure.2020.12.006","article-title":"Anticipatory anxiety of epileptic seizures: an overlooked dimension linked to trauma history","volume":"85","author":"Ertan","year":"2021","journal-title":"Seizure"},{"key":"10.1016\/j.yebeh.2022.108811_b0100","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1016\/j.yebeh.2018.12.007","article-title":"A hospital-based study on caregiver preferences on acute seizure rescue medications in pediatric patients with epilepsy: intranasal midazolam versus rectal diazepam","volume":"92","author":"Nunley","year":"2019","journal-title":"Epilepsy Behav"},{"key":"10.1016\/j.yebeh.2022.108811_b0105","doi-asserted-by":"crossref","first-page":"12086","DOI":"10.21037\/apm-21-2404","article-title":"Effect of self-management interventions for adults with epilepsy: a systematic review and meta-analysis","volume":"10","author":"Li","year":"2021","journal-title":"Ann Palliat Med"}],"container-title":["Epilepsy & Behavior"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1525505022002608?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1525505022002608?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,26]],"date-time":"2025-10-26T18:50:44Z","timestamp":1761504644000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1525505022002608"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,9]]},"references-count":21,"alternative-id":["S1525505022002608"],"URL":"https:\/\/doi.org\/10.1016\/j.yebeh.2022.108811","relation":{},"ISSN":["1525-5050"],"issn-type":[{"value":"1525-5050","type":"print"}],"subject":[],"published":{"date-parts":[[2022,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Quality-of-life results in adults with epilepsy using diazepam nasal spray for seizure clusters from a long-term, open-label safety study","name":"articletitle","label":"Article Title"},{"value":"Epilepsy & Behavior","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.yebeh.2022.108811","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 The Authors. Published by Elsevier Inc.","name":"copyright","label":"Copyright"}],"article-number":"108811"}}